Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:bannedIn |
professional sports
|
| gptkbp:benefit |
selective tissue targeting
|
| gptkbp:compatibleWith |
FDA for general use
|
| gptkbp:contrastsWith |
gptkb:anabolic_steroids
|
| gptkbp:example |
Ligandrol
Ostarine Testolone |
| https://www.w3.org/2000/01/rdf-schema#label |
SARM
|
| gptkbp:mechanismOfAction |
binds to androgen receptors
|
| gptkbp:regulates |
gptkb:World_Anti-Doping_Agency
|
| gptkbp:routeOfAdministration |
oral
injectable |
| gptkbp:sideEffect |
liver toxicity
hormonal imbalance |
| gptkbp:standsFor |
Selective Androgen Receptor Modulator
|
| gptkbp:studiedBy |
age-related muscle loss
cancer cachexia |
| gptkbp:usedFor |
muscle growth
treatment of osteoporosis treatment of muscle wasting |
| gptkbp:bfsParent |
gptkb:Southern_Appalachia_Railway_Museum
gptkb:MK-677 |
| gptkbp:bfsLayer |
7
|